In human clinical use, reported side effects are generally mild and transient: Mild injection site redness or discomfort (resolves within hours) Transient nausea in some patients, particularly early in the protocol Mild dizziness or light-headedness (rare, typically dose-related) Temporary fatigue in the first few days (often a sign of active tissue remodeling) No significant systemic toxicity, organ damage, hormonal suppression, or addiction potential has been documented in the published literature
If anything other than sterile saline was added, it may have been a preservative that you had reacted to
Secondly, cycling Ipamorelin use can help prevent desensitization of the GH receptors, which can occur with prolonged and continuous usage
Other GH Secretagogues Selection Criteria: Choose Ipamorelin for: Isolated GHS-R1a studies, clean GH secretion research, selective receptor pharmacology, minimal confounding variables Choose GHRP-2/GHRP-6 for: Studies requiring broader hormonal activation, comparative selectivity research, multi-axis investigations ANALYTICAL VERIFICATION: BIONIX Ipamorelin undergoes comprehensive analytical characterization
[3] Gwyer, D., Wragg, N
:format(jpg)/f.elconfidencial.com%2Foriginal%2Ff27%2Fb3a%2F460%2Ff27b3a460e92bcdc8635b6aa1b0eff12.jpg)
